Previous Section
Drug Therapy
11. Long-acting injectable risperidone for the treatment of schizophrenia : clinical perspectives.
- Author
- Moller HJ;
- Institution
- Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
- Journal
- Drugs. 2007;67(11):1541-66.
- Abstract URL
- Click here to view abstract
12. The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: A 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.
- Author
- Ritsner MS; Yorkov V; Ratner Y; Soifer P; Gibel A;
- Institution
- Sha'ar Menashe Mental Health Center, Mobile Post Hefer 38814, Israel; Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
- Journal
- Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jul 4;.
- Abstract URL
- Click here to view abstract
13. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: A 12-month, open-label, flexible-dose, naturalistic observational trial.
- Author
- Ratner Y; Gibel A; Yorkov V; Ritsner MS;
- Institution
- Acute Department, Sha'ar Menashe Mental Health Center, Mobile Post Hefer 38814, Hadera, Israel.
- Journal
- Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 21;.
- Abstract URL
- Click here to view abstract
14. Antipsychotic Medication for Childhood-Onset Schizophrenia.
- Author
- Kennedy E; Kumar A; Datta SS;
- Institution
- 2Child and Family Department, Tavistock Clinic, 120 Belsize Lane, London NW3 5BA, UK.
- Journal
- Schizophr Bull. 2007 Aug 1;.
15. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia.
- Author
- Usall J; Suarez D; Haro JM;
- Institution
- Sant Joan de Deu-Serveis de Salut Mental, Fundacio Sant Joan de Deu, Sant Boi de Llobregat, Barcelona, Spain.
- Journal
- Psychiatry Res. 2007 Aug 1;.
- Abstract URL
- Click here to view abstract
16. Agitation associated with aripiprazole initiation.
- Author
- Lea JW; Stoner SC; Lafollette J;
- Institution
- 1 University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri; Northwest Missouri Psychiatric Rehabilitation Center, St. Joseph, Missouri.
- Journal
- Pharmacotherapy. 2007 Sep;27(9):1339-42.
- Abstract URL
- Click here to view abstract
17. Pharmacogenetics and schizophrenia.
- Author
- Foster A; Miller del D; Buckley PF;
- Institution
- Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA. afoster@mcg.edu <afoster@mcg.edu>
- Journal
- Psychiatr Clin North Am. 2007 Sep;30(3):417-35.
- Abstract URL
- Click here to view abstract
18. Prevalence of the metabolic syndrome among patients receiving clozapine.
- Author
- Lamberti JS; Olson D; Crilly JF; Olivares T; Williams GC; Tu X; Tang W; Wiener K; Dvorin S; Dietz MB;
- Institution
- Department of Psychiatry, University of Rochester Medical Center, 300 Crittenden Blvd., Rochester, NY 14642, USA. steve_lamberti@urmc.rochester.edu
- Journal
- Am J Psychiatry. 2006 Jul;163(7):1273-6.
- Abstract URL
- Click here to view abstract
19. Association of initial antipsychotic response to clozapine and long-term weight gain.
- Author
- Bai YM; Lin CC; Chen JY; Lin CY; Su TP; Chou P;
- Institution
- Community Medicine Research Center and Institute of Public Health, National Yang-Ming University,155 Li-Nong St., Sec. 2, Shihpai, Taipei 112, Taiwan.
- Journal
- Am J Psychiatry. 2006 Jul;163(7):1276-9.
- Abstract URL
- Click here to view abstract
Next: Clinical Trials
